The second Trump administration's abrupt halt on government funding has thrown crucial medical research, including cancer research, into disarray. The Department of Health and Human Services has been instructed to pause all grant proposals and funding, causing widespread confusion and uncertainty within the National Institutes of Health (NIH). Meetings and reviews have been indefinitely suspended, leaving the future of billions of dollars in research programs, including foreign aid, in limbo.
The second Trump administration's draconian rollbacks have put cancer research and other crucial government-funded medical projects on the chopping block.
Cancer researcher Chrystal Starbird of the University of North Carolina's Medical Center was preparing to sit on her first NIH grant review panel later this month when she got an email telling her, essentially, not to show up.With that one-two punch, the state of funding for any new trials — and for billions of dollars worth of other important programs, including foreign aid — remains on hold, its future uncertain.
Ironically, this bizarre suspension of NIH research may end up putting the US behind China and other science rivals.after the pause was first enacted. "Even short delays will put the United States behind in research."
Cancer Research NIH Funding Government Grants Medical Projects Research Delays
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Trump Administration Threatens Global Health CooperationThe article warns that the Trump administration's policies could significantly weaken the U.S. role in global health and negatively impact international health cooperation.
Read more »
Trump administration tells health agencies to suspend all public communicationsPolitical News and Conservative Analysis About Congress, the President, and the Federal Government
Read more »
Trump Administration Freezes Federal Health Agency CommunicationsThe Trump administration has implemented a freeze on many federal health agency communications with the public, including regulations, guidance, press releases, and social media posts, until they are approved by a political appointee. This pause, in effect through February 1st, affects agencies like the CDC, NIH, and FDA.
Read more »
Trump Administration Freezes Communications From Federal Health AgenciesThe Trump administration has ordered an immediate pause on public communications from federal health agencies, including the CDC, NIH, and FDA, until they are approved by a political appointee. The freeze affects regulations, guidance, announcements, press releases, social media posts, and website content, raising concerns about potential delays in disseminating critical health information.
Read more »
Trump Administration Pauses Public Communications at Federal Health AgenciesActing Secretary of Health and Human Services, Dr. Dorothy Fink, has ordered a temporary halt on public communications from all federal health agencies, including the CDC, FDA, and NIH, pending review by presidential appointees. The pause, effective immediately and lasting until February 1st, aims to ensure all communications align with the new administration's guidance. While the move is not unprecedented during transitions, it raises concerns about potential delays in critical health information, particularly concerning the escalating bird flu outbreak.
Read more »
Trump Administration Freezes Health Agency CommunicationsThe Trump administration has implemented a freeze on numerous health agency reports and public communications, including those from the CDC and FDA. The freeze aims to review and control all outgoing communications until they are approved by political appointees.
Read more »